Source: Benzinga

BMS: Evotec And Bristol Myers Squibb Enter Exclusive Global Licence Agreement For Selected Programmes Developed And Progressed In The Collaboration

Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday. Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!

Read full article »
Annual Revenue
$10-50B
Employees
10-50K
Christopher Boerner's photo - CEO of Bristol-Myers Squibb

CEO

Christopher Boerner

CEO Approval Rating

46/100

Read more